Catherine Mazzacco - 06 Mar 2023 Form 3 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Director
Signature
/s/ Krish Krishnan, as attorney-in-fact for Catherine Mazzacco
Issuer symbol
KRYS
Transactions as of
06 Mar 2023
Net transactions value
$0
Form type
3
Filing time
09 Mar 2023, 17:26:34 UTC
Next filing
04 Apr 2023

No securities are beneficially owned.